Makale
Tam Makale
Uluslararası
2017
Repeated Courses of Oral Ibuprofen in Premature Infants with Patent Ductus Arteriosus: Efficacy and Safety
PEDIATRICS AND NEONATOLOGY
Cilt 58 · Sayı 1 · ss. 29–35 · 01.02.2017
Özet
BACKGROUND: There are limited data about the results of repeated oral ibuprofen (OIBU) treatment. This study aimed to describe patent ductus arteriosus (PDA) closure rates and adverse events after repeated courses of OIBU in premature infants with PDA.
Anahtar kelimeler
Ibuprofen
risk factors
Indomethacin
CONTROLLED TRIAL
Preterm infants
CLOSURE
PROPHYLAXIS
Patent ductus arteriosus
multiple course
BIRTH-WEIGHT INFANTS
BILIRUBIN-ALBUMIN BINDING
MULTIPLE COURSES
Atıf için künye
Olgun, H., Ceviz, N., KARTAL, I., Caner, I., KARACAN, M., TAŞTEKİN, A., & Becit, N. (2017). Repeated Courses of Oral Ibuprofen in Premature Infants with Patent Ductus Arteriosus: Efficacy and Safety. PEDIATRICS AND NEONATOLOGY, 58(1), 29–35. https://doi.org/10.1016/j.pedneo.2015.04.017
BibTeX
@article{olgun2017-223434,
author = {Olgun, Haşim and Ceviz, Naci and KARTAL, Ibrahim and Caner, Ibrahim and KARACAN, Mehmet and TAŞTEKİN, Ayhan and Becit, Necip},
title = {Repeated Courses of Oral Ibuprofen in Premature Infants with Patent Ductus Arteriosus: Efficacy and Safety},
journal = {PEDIATRICS AND NEONATOLOGY},
year = {2017},
volume = {58},
number = {1},
pages = {29--35},
issn = {1875-9572},
doi = {10.1016/j.pedneo.2015.04.017},
url = {https://akademik.atauni.edu.tr/yayinlar/223434-repeated-courses-of-oral-ibuprofen-in-premature-infants-with-patent-ductus}
}